Orlando, FL -- (SBWIRE) -- 10/29/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On MannKind Corporation (NASDAQ:MNKD), Dynavax Technologies Corporation(NASDAQ:DVAX).
MannKind Corporation (NASDAQ:MNKD) shares declined 1.60% to $5.24. The company will release its 2013 third quarter financial results on Monday, November 4, 2013 and its management will host a conference call to discuss the third quarter financial results and other Company developments at 5:00 PM (Eastern Time) on November 4, 2013.
Additionally, Zacks restated their neutral rating on shares of MNKD in a research note issued to investors on Oct. 17. The firm currently has a $5.50 price target on the stock.
Moreover, the company on Oct. 14 announced the resubmission on October 13, 2013 of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of AFREZZA® (insulin human [rDNA origin]) Inhalation Powder with an indication to improve glycemic control in adults with type 1 or type 2 diabetes.
Are investors worried about the recent updates with MNKD? Find out with a free trend analysis HERE
Dynavax Technologies Corporation(NASDAQ:DVAX) shares increased 7.14% to $1.35. The company on Oct. 25 announced the pricing of previously announced concurrent, separate underwritten offerings of (i) 79,570,000 shares of its common stock at a price to the public of $1.075, for expected gross proceeds of $85.5 million and (ii) 43,430 shares of its Series B Convertible Preferred Stock ("Series B") at a price to the public of $1,075.00, for expected gross proceeds of $46.7 million. The Series B is non-voting and each share of Series B is convertible into 1,000 shares of Dynavax common stock, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than 9.98% of the total number of shares of Dynavax common stock then outstanding.
Is DVAX going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)